NACT(Neoadjuvant Chemotherapy)
Showing 1 - 25 of >10,000
BRCA and NACT in TNBC Patients
Completed
- Triple-Negative Breast Cancer
- BRCA1/2 genetic testing
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)
Recruiting
- Ovarian Cancer
- +2 more
- Paclitaxel
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 13, 2023
Cervical Cancer Trial in Chengdu (NACT, CCRT, Brachytherapy)
Not yet recruiting
- Cervical Cancer
- NACT
- +2 more
-
Chengdu, Sichuan, ChinaSicchuan cancer hospital
Dec 28, 2021
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Primary debulking surgery, Neoadjuvant
Not yet recruiting
- Ovarian Cancer
- +2 more
- Primary debulking surgery
- +2 more
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Jan 17, 2022
Epithelial Carcinoma, Ovarian, Neoadjuvant Chemo Trial in Chendu (cisplatin i.p.)
Recruiting
- Epithelial Carcinoma, Ovarian
- Neoadjuvant Chemotherapy
- cisplatin i.p.
-
Chendu, Sichuan, ChinaWest China Second University Hospital of Sichuan University
Aug 3, 2021
New Prognostic Index for Neoadjuvant Chemotherapy Outcome in
Enrolling by invitation
- Ovarian Cancer
- +2 more
- CRS scoring
- Routine blood laboratory testing before treatment
-
Guangzhou, Guangdong, ChinaThe Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023
Cervical Cancer, Chemo Effect, Programmed Cell Death 1 Receptor / Antagonists & Inhibitors Trial (Sindilimab +paclitaxel+
Not yet recruiting
- Cervical Cancer
- +3 more
- Sindilimab +paclitaxel+ cisplantin
- (no location specified)
Mar 14, 2021
Surgery After Neoadjuvant Chemotherapy in Locally Advanced
Completed
- Postoperative Complications
- surgery after neoadjuvant chemotherapy
-
Seoul, Korea, Republic ofAsan medical center
Jun 1, 2023
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in China, Korea, Republic of (Upfront
Recruiting
- Epithelial Ovarian Cancer
- +2 more
- Upfront cytoreductive surgery
- Interval debulking surgery
-
Guangzhou, Guangdong, China
- +7 more
Oct 8, 2021
Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva Trial (Paclitaxel and Carboplatin, Chemoradiation)
Not yet recruiting
- Locally Advanced Vulvar Carcinoma
- Squamous Cell Carcinoma of the Vulva
- Paclitaxel and Carboplatin
- Chemoradiation
- (no location specified)
Jun 6, 2023
Ovarian Cancer Trial (Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Neoadjuvant Chemotherapy
Completed
- Ovarian Cancer
- Cytoreductive Surgery (CRS)
- +4 more
- (no location specified)
Mar 17, 2021
Breast Cancer Trial in New York (Harmonic motion imaging)
Recruiting
- Breast Cancer
- Harmonic motion imaging
-
New York, New YorkColumbia University Irving Medical Center/NYP
Nov 7, 2022
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (GEN-1, Carboplatin,
Recruiting
- Epithelial Ovarian Cancer
- +2 more
- GEN-1
- +2 more
-
Birmingham, Alabama
- +23 more
Mar 7, 2022
Sentinel Lymph Node Trial (sentinle lymphnode biopsy)
Not yet recruiting
- Sentinel Lymph Node
- sentinle lymphnode biopsy
- (no location specified)
Nov 11, 2023
HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response Trial in Beijing (Camrelizumab with vinorelbine
Recruiting
- HER2-negative Breast Cancer
- +5 more
- Camrelizumab with vinorelbine and cisplatin
-
Beijing, Beijing, ChinaPeking University First Hospital
Oct 15, 2022
Breast Cancer, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy Trial in Fuzhou (carbon dye)
Recruiting
- Breast Cancer
- +2 more
- carbon dye
-
Fuzhou, Fujian, ChinaStudy Officials
Aug 22, 2022
Hyperthermic Intraperitoneal Chemo, Neoadjuvant Chemo Trial in Guangzhou (HIPEC, intravenous chemo)
Recruiting
- Hyperthermic Intraperitoneal Chemotherapy
- Neoadjuvant Chemotherapy
- HIPEC
- intravenous chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen Memorial Hospital
Feb 17, 2022
Breast Cancer, Triple Negative Breast Cancer Trial in New York (Sodium (Na) Magnetic Resonance Imaging (MRI), Dynamic Contrast-
Terminated
- Breast Cancer
- Triple Negative Breast Cancer
- Sodium (Na) Magnetic Resonance Imaging (MRI)
- Dynamic Contrast- Enhanced (DCE) MRI
-
New York, New YorkNYU Langone Health
Aug 1, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +17 more
- Biopsy
- +3 more
-
Augusta, Georgia
- +4 more
Jan 25, 2023
Preoperative Radiotherapy for Non-responder Patients After
Completed
- Breast Neoplasms
- +3 more
- Radiotherapy
-
Istanbul, TurkeyIstanbul Breast Society
Mar 1, 2022
Gastric Cancer, Neoadjuvant Chemo Trial in Qingdao (live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules)
Recruiting
- Gastric Cancer
- Neoadjuvant Chemotherapy
- live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
-
Qingdao, Shandong, ChinaDepartment of Gastrointestinal Surgery, Qingdao University Affil
Jun 4, 2023
Breast Cancer Trial in Gothenburg (MagTrace only, MagTrace and Magseed)
Recruiting
- Breast Cancer
- MagTrace only
- MagTrace and Magseed
-
Gothenburg, SwedenSahlgrenska University Hospital
Nov 22, 2022
Colon Cancer Trial (Neoadjuvant chemo)
Not yet recruiting
- Colon Cancer
- Neoadjuvant chemotherapy
- (no location specified)
Oct 25, 2023
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Primary debulking surgery,
Not yet recruiting
- Epithelial Ovarian Cancer
- +2 more
- Primary debulking surgery
- +2 more
-
Shanghai, Shanghai, China
- +3 more
Aug 25, 2020